Feed Anticoccidials Market Size, Share, and Analysis By Livestock (Poultry, Ruminants, Swine, and Others), By Source (Chemical and Natural), By Type (Monensin, Salinomycin, Narasin, Diclazuril, and Others), and Regional Forecast, 2024-2032

Coccidiosis is a type of gastrointestinal infection of animals caused by coccidian protozoa. The disease spreads through contact with infected feces of infected tissue with another animal. The primary symptom of Coccidiosis is diarrhea, which may have indications of blood in severe cases. Most coccidiosis in poultry belong to the genus Eimeria and is highly host-specific. Coccidiosis is diagnosed mostly in cattle than in any other mammalian species. The disease causes diarrhea in calves and young growing stock, often decreasing production.

Coccidiosis causes significant economic losses due to reduced performance and death from direct animal infections. It is a significant concern in the poultry sector worldwide due to its direct effect on enteric health and flock appearance. According to EW Nutrition Technical Team, coccidial infection is a devastating enteric challenge in the poultry industry, costing over USD 14 billion annually. The disease causes production losses due to intestinal cell injuries such as higher feed conversion rates, lower body weights, failures in skin pigmentation, lack of flock uniformity, and in the end, mortality. Thus, to overcome the losses and improve farm profitability, there is a surge in the use of anticoccidials in feeds.

Impact of COVID-19 on the Global Feed Anticoccidials Market

The COVID-19 pandemic has impacted the global feed anticoccidials market growth in multiple ways. The pandemic has disrupted supply chains, causing shortages of raw materials, transportation delays, and increased costs, affecting the production and availability of feed anticoccidials. Consumer behavior changes led to fluctuations in animal product demand and restaurant closures reduced the demand for poultry and eggs. In contrast, increased pet food demand may have boosted the need for feed anticoccidials in the companion animal sector.

Key Insights

The report will cover the following key insights:

• Parent market overview


• Macro-economic factors


• COVID-19 impact on the feed anticoccidials market


• Industry growth and impact


• Porter's five forces analysis


• Industry dynamics – drivers, restraints, and opportunities


• Market trends, recent developments, and new product launch


• Market sizing, estimation, forecasting, and growth prospects


• Regional analysis of the global feed anticoccidials market

Analysis by Livestock

The poultry segment is expected to account for a significant feed anticoccidials market share. Coccidiosis is majorly seen in chickens, which is one of the significant factors contributing to a major share of the poultry segment. The disease damages the intestinal tract and prevents the animal from absorbing nutrients vital for survival. The severity of the disease disrupts the poultry industry economically. Therefore, several companies have launched new environmentally and economically sustainable products that support the bird’s microbiome. For instance, in June 2022, Kemin Industries announced the launch of a microbial solution, ENTEROSURE. The new product helps to promote, restore, and maintain a healthy gut microbiome of the animal by inhibiting and managing the growth of enteric pathogens such as Clostridium perfringens and Escherichia coli. Based on these results, such products help prevent coccidiosis and increase the demand for feed anticoccidials.

Analysis by Source

Based on source, the natural segment is expected to grow at a high CAGR over the forecast period. There is an increase in demand for antibiotic-free chicken among consumers. Also, the long-term use of antibiotics, anticoccidial drugs, and vaccinal reactions results in resistance acquisition, leading to less animal productivity. Thus, natural feed anticoccidials are reinforced to improve protective efficacy against several pathogenic bacteria and parasites. For instance, in August 2020, Pathway Intermediates, an animal nutrition brand, launched Q – Life, a natural alternative solution to treat coccidials. The product helps improve animal performance, control coccidiosis, and leave no residue in animals.

Analysis by Type

The salinomycin segment is expected to account for a major share of the global feed anticoccidials market based on type. Salinomycin is a well-known coccidiostat and antibacterial drug added to feed for curing coccidiosis disease in animals such as poultry, ruminants, and swine. The availability of salinomycin in all weather conditions with low prices helps gain traction among poultry farmers. Salinomycin drug has a coccidiocidal effect on sporozoites and merozoites, which results in minimized damage to the intestinal cells of animals, and thus increases its demand in livestock.

Analysis by Region

To gain extensive insights into the market, Request for Customization

North America is anticipated to account for a major market revenue for the global feed anticoccidials market. According to the United States Department of Agriculture (USDA), Foreign Agricultural Service, January 2022, the U.S. poultry industry is the world’s largest meat and egg producer and second largest exporter of poultry meat. Also, the consumption of poultry meat is higher in the U.S. than other meat such as beef and pork. To meet the growing demand for meat products in the region, the companies must introduce technologies to improve the health of the livestock population. For instance, in March 2021, Elanco Animal Health Incorporated, a company delivering products and services to treat disease in farm animals and pets, launched three anticoccidial feeds – ZoaShield, Clinacox, and Cosabody. This product portfolio expansion helped the company meet the unmet needs of producers with antibiotic alternatives and protect the animal’s health.      

Key Market Players 

Major players in the feed anticoccidials market include Elanco Animal Health Incorporated, Ceva Animal Health, Phibro Animal Health, Huvepharma, Impextraco, Zoetis, Merck Animal Health, Qilu Animal Health Products, Kemin Industries, and Pathway Intermediates.

Segmentation

Key Industry Developments

• In October 2020, Huvepharma, one of the leading pharmaceutical companies, launched the new coccidiosis control product Monimax in Europe. The product is proven to control coccidiosis and is sold in many parts of the world. The product is an ideal solution for feed mills and is used in chickens and turkeys.


• In August 2020, Merck Animal Health, a veterinary product, technology, and veterinary service company, announced the acquisition of the worldwide rights to VECOXAN (diclazuril). The product is an oral suspension from Elanco Animal Health to prevent coccidiosis in calves and lamb.